The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report

Kirsi Santti, Annette Beule, Mikko Rönty, Hanna Ihalainen, Maija Tarkkanen, Carl Blomqvist

Research output: Contribution to journalLetterScientific

Original languageEnglish
JournalActa Oncologica
Volume58
Issue number6
Pages (from-to)897-900
Number of pages4
ISSN0284-186X
DOIs
Publication statusPublished - 3 Jun 2019
MoE publication typeB1 Journal article

Fields of Science

  • CYCLIN D1 OVEREXPRESSION
  • EXPRESSION
  • THERAPY
  • BETA
  • PATHWAY
  • IMPACT
  • 3122 Cancers

Cite this